Androgen therapy in women: for whom and when

Author： Pluchino Nicola   Carmignani Arianna   Cubeddu Alessandra   Santoro Anna   Cela Vito   Alcalà Tania  

Publisher： Springer Publishing Company

ISSN： 0932-0067

Source： Archives of Gynecology and Obstetrics, Vol.288, Iss.4, 2013-10, pp. : 731-737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Androgen therapy in women, beyond libido

By Davis S. R.  

Climacteric, Vol. 16, Iss. 1, 2013-08 ,pp. : 18-24

Informa Healthcare

Access to resources Recommend Favorite

Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports

By Gambrell R. D.   Natrajan P. K.  

Climacteric, Vol. 9, Iss. 3, 2006-06 ,pp. : 224-233

Informa Healthcare

Access to resources Recommend Favorite

Androgen replacement therapy and cardiovascular function

By Genazzani A. R.   Pluchino N.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 102-107

Informa Healthcare

Access to resources Recommend Favorite

Sexual function in women with complete androgen insensitivity syndrome

By Minto C.L.   Liao K.L.-M.   Conway G.S.   Creighton S.M.  

Fertility and Sterility, Vol. 80, Iss. 1, 2003-07 ,pp. : 157-164

Elsevier

Access to resources Recommend Favorite

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

By Azziz R.   Ehrmann D.A.   Legro R.S.   Fereshetian A.G.   O'Keefe M.   Ghazzi M.N.   PCOS/Troglitazone Study Group  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 932-937

Elsevier

Access to resources Recommend Favorite